Exploring Nonmotor Neuropsychiatric Manifestations of Parkinson Disease in a Comprehensive Care Setting
Open Access
- 3 April 2020
- journal article
- review article
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 34 (3) , 181-195
Abstract
Parkinson disease (PD) is a debilitating neurological condition that includes both motor symptoms and nonmotor symptoms (NMS). Psychiatric complaints comprise NMS and are collectively referred to as neuropsychiatric manifestations. Common findings include atypical depressive symptoms, anxiety, psychosis, impulse control disorder, deterioration of cognition, and sleep disturbances. Quality of life (QoL) of patients suffering from NMS is greatly impacted and many times can be more debilitating than motor symptoms of PD. We expand on knowledge gained from treatment models within a comprehensive care model that incorporates multidisciplinary specialists working alongside psychiatrists to treat PD. Insight into background, clinical presentations, and treatment options for patients suffering from neuropsychiatric manifestations of PD are discussed. Identifying symptoms early can help improve QoL, provide early symptom relief, and can assist tailoring treatment plans that limit neuropsychiatric manifestations.Keywords
This publication has 160 references indexed in Scilit:
- Prevalence of Psychotic Symptoms in a Community-Based Parkinson Disease SampleThe American Journal of Geriatric Psychiatry, 2012
- MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCIMovement Disorders, 2011
- Daytime Napping, Nighttime Sleeping, and Parkinson DiseaseAmerican Journal of Epidemiology, 2011
- Patient versus informant reporting of ICD symptoms in Parkinson’s disease using the QUIP: Validity and variabilityParkinsonism & Related Disorders, 2011
- Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER)Movement Disorders, 2010
- Violent behavior during sleep: Prevalence, comorbidity and consequencesSleep Medicine, 2010
- Treatment of insomnia in Parkinson's disease: A controlled trial of eszopiclone and placeboMovement Disorders, 2010
- Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's diseaseMovement Disorders, 2009
- The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's diseaseMovement Disorders, 2009
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995